ParthOnGrowth

📈 Equities & Investing | 🇮🇳 India Growth
💪 Health & Fitness | ✈️ Travel | 🍲 Food

Not SEBI Registered. Views are personal.

[ParthOnGrowth @ParthOnGrowth]

https://t.co/ihtSfYRgE7

[ParthOnGrowth @ParthOnGrowth]

Trump may end up doing more damage to the global economy than anyone expected.

Add to that the Iran conflict, rising geopolitical tensions, and tariff wars, and we're entering a period of prolonged uncertainty.

India won't be spared. Foreign capital hates uncertainty. Exports slow down, supply chains get disrupted, crude oil prices remain volatile, and market valuations get compressed.

The next 1-2 years could be painful for Indian equities despite strong domestic fundamentals. Sentiment matters more than fundamentals in the short term.

Stay cautious. Stay invested. Don't expect a smooth ride.

#India #StockMarket #Nifty50 #Trump #Tariffs #Iran #Geopolitics #IndianEconomy #Investing #Markets #FIIs #LongTermInvesting

[ParthOnGrowth @ParthOnGrowth]

#Waaree Energies is down, but fundamentally NOTHING has changed.Why is the stock falling then? Let's separate business from sentiment.

📉 ALMM policy delays have hurt near-term sentiment.

🌍 Global uncertainties around tariffs and trade policies continue to weigh on the renewable sector.

🇺🇸 After Trump's proposed pharma tariffs, the market is asking, "What if renewables are next?" Markets hate uncertainty and are pricing in future risks today.

🏦 Brokerage downgrades and valuation cuts have added further pressure.

The important part?None of these change Waaree's long-term fundamentals.

📦 Order book remains strong (~₹53,000 Cr).

🏭 Massive integrated manufacturing capacity is being built.

⚡ India's solar demand story remains intact.

🚀 The company continues to expand across Solar Cells, Modules, BESS and Renewable Energy.

The market is pricing in fear, not weak fundamentals.

India's solar story remains intact. Waaree's order book, capacity expansion and long-term opportunity remain unchanged.

Short-term: Pain. Long-term: Bullish on India's renewable sector.

#WaareeEnergies #Renewables #Solar #Investing #IndianStockMarket #EnergyTransition #LongTermInvesting #Nifty

[ParthOnGrowth @ParthOnGrowth]

Why did #Waaree Energies fall ~3% today and nearly 10% over the last week? Is the long-term story broken?

Short answer: NO.

Here’s what’s happening 👇

📉 Recent correction is largely due to:
ALMM List-II policy delays.
Brokerage downgrades (UBS cut its target price).
Near-term margin concerns.
Sector-wide weakness in Indian solar stocks.
⚠️ The market is NOT worried about demand. It’s worried about execution and valuations.
🇮🇳 India’s solar story remains intact. India added ~44.6 GW of solar capacity in FY26 alone and is targeting 500 GW of non-fossil fuel capacity by 2030.
📦 Waaree’s order book stands at ~₹53,000 Cr, providing strong revenue visibility.
🏭 Waaree isn’t just a solar module company anymore. It is building an integrated renewable energy ecosystem:
Solar Cells
Solar Modules
Battery Energy Storage Systems (BESS)
EPC Business
Renewable Power Generation
🚀 Planned manufacturing capacities:
~15.4 GW Solar Modules
~10 GW Solar Cells
🇮🇳 Even if Waaree captures only a fraction of India’s solar opportunity, its factories could remain busy for many years.
❌ ALMM delays do NOT kill the investment thesis. They only delay some of the near-term benefits for domestic cell manufacturers.
💰 The ₹30,000 Cr capex is both the biggest opportunity and the biggest risk. The market wants proof that management can execute efficiently and generate high ROCE.

What the market is saying today:

“Show me execution, margins and returns on capital.”

What long-term investors should ask:

“Where will India’s solar demand and Waaree’s market position be in 2030?”

The biggest mistake investors make is confusing stock price weakness with business weakness.

Bear Case: Execution risk.

Bull Case: One of India’s largest integrated solar manufacturing companies riding a multi-decade renewable energy opportunity.

If management executes over FY27-FY29, today’s correction may simply be a speed bump in a much larger growth story.

Not SEBI registered. Views are personal.

#WaareeEnergies #Solar #Investing #Renewables #IndianStockMarket #LongTermInvesting #MakeInIndia #EnergyTransition

[ParthOnGrowth @ParthOnGrowth]

The market didn’t like #Newgen’s Q1. I liked it even more after reading the concall. Here’s why 👇

🔹 Revenue delay, NOT demand slowdown.

🔹 ₹12 Cr revenue expected to be recovered in Q2/Q3.

🔹 Revenue +11% YoY | PAT +26% YoY.

🔹 ~88% recurring revenue = predictable cash flows.

🔹 🇺🇸 US business grew 27% YoY (subscription-led).

🔹 🤖 AI is already being monetized in Banking, Insurance & Healthcare.

🔹 💰 Larger deal wins (₹15-27 Cr) are becoming the norm.

🔹 👨‍💼 Smooth CEO transition with a 33-year Newgen veteran.

🔹 🌍 Strong global pipeline across India, US & EMEA.

🔹 🚀 I believe Newgen is building a global Enterprise AI platform that could be a multi-bagger over the next decade.

The market sees a weak quarter. I see a potential 10-year compounder.

Not SEBI registered. Views are personal. DYOR.

#NewgenSoftware #Multibagger #AI #IndianStocks #Nifty

[ParthOnGrowth @ParthOnGrowth]

#Waaree Energies: UBS Downgrade – Should Investors Worry? 🤔

Here’s my takeaway after reading the UBS report and comparing it with the company’s fundamentals:

🏭 Business remains strong – Revenue, EBITDA and PAT have shown exceptional growth over the last year.
📦 Strong order book (~₹53,000 Cr) provides good visibility for future growth.
⚡ Massive expansion plans – ₹30,000 Cr capex to build India’s most integrated solar manufacturing ecosystem.
🚀 Capacity expansion to ~15.4 GW modules & 10 GW cells/ingot-wafer can strengthen its leadership position.
📉 UBS has cut the target price because it expects lower valuation multiples and margin pressure in the near to medium term.
🏗️ The biggest risk is execution, not demand. Markets want proof that management can deliver on its ambitious plans.
🌍 Solar manufacturing is a cyclical business. Margins can fluctuate due to competition, tariffs, government policies and global pricing.
🇺🇸 The U.S. business remains a key variable and could significantly impact profitability going forward.
💰 The market is concerned about whether the ₹30,000 Cr capex will generate high ROCE and strong cash flows.
⏳ Waaree is currently in its “Execution Phase”. Institutions are waiting for FY27–FY28 numbers before assigning a premium valuation.

My View:

❌ This is NOT a “business is broken” story.
⚠️ This is a “valuation reset + execution risk” story.
📉 Short-term sentiment: Negative.
📈 Long-term thesis: Intact, if management executes well.

What I’ll Track Closely:

EBITDA margins.
ROCE & free cash flows.
Order book growth.
Capex execution timelines.
Debt levels.
U.S. business performance.

Bottom Line: The stock hasn’t underperformed because the business is weak. The market is simply saying:

“Show me the execution, and I’ll pay a premium.”

Not SEBI registered. Views are personal.

#WaareeEnergies #Solar #Investing #IndianStockMarket #StocksToWatch #LongTermInvesting #Nifty

[ParthOnGrowth @ParthOnGrowth]

The tweet is #Newgen is up 14% today

#GiftNifty #Nifty50 #Sensex #StockMarket #IndianMarkets #Investing #MarketWrap #FII #DII #EarningsSeason #HCLTech #ITStocks #DalalStreet

[ParthOnGrowth @ParthOnGrowth]

Over the past few days, I’ve been researching high-quality Indian businesses.

These companies stood out for their high ROE, strong cash generation, asset-light business models, and long-term wealth creation potential.

🧬 Zydus Lifesciences
📊 ROE: ~25% | P/E: ~22x | P/B: ~4.6x

📈 CARE Ratings
📊 ROE: ~20% | P/E: ~34x | P/B: ~6.5x

⚡ Indian Energy Exchange (IEX)
📊 ROE: ~39% | P/E: ~22x | P/B: ~8.2x

🤖 eClerx Services
📊 ROE: ~36% | P/E: ~33x | P/B: ~12.6x

🚆 IRCTC
📊 ROE: ~35% | P/E: ~45x | P/B: ~16x

☀️ Waaree Energies
📊 ROE: ~35% | P/E: ~45x | P/B: ~10x

💻 Newgen Software
📊 ROE: ~24% | P/E: ~55x | P/B: ~11x

💊 Lupin
📊 ROE: ~20% | P/E: ~29x | P/B: ~5.5x

🌍 BLS International
📊 ROE: ~30% | P/E: ~28x | P/B: ~6x

🚗 KPIT Technologies
📊 ROE: ~35% | P/E: ~55x | P/B: ~18x

Common characteristics I found across these businesses:

✅ High ROE
💰 Strong cash generation
🏦 Low debt
🏆 Asset-light business models
📈 Structural growth tailwinds
👨‍💼 Proven management execution

These aren’t buy recommendations—just companies that have earned a place on my long-term watchlist after extensive fundamental research.

Not SEBI registered. Views are personal. Please do your own research before investing.

#IndianStocks #Investing #LongTermInvesting #StockMarket #WealthCreation #Nifty

[ParthOnGrowth @ParthOnGrowth]

📊 Market Wrap | July 13, 2026

🇮🇳 Markets Stay Resilient
🟢 Nifty 50: 24,211 (+0.02%)
🟢 Sensex: 77,616 (+0.06%)
➡️ Markets absorbed early geopolitical jitters and closed almost flat.

💰 Institutional Activity
🔴 FII: Sold ₹3,062 Cr
🟢 DII: Bought ₹2,172 Cr
��️ Domestic institutions continued to cushion FII selling.

💻 Sector Spotlight
🏆 Nifty IT: +3.59% (Top Performer)
🚀 Strong buying after HCLTech’s impressive Q1 earnings.

🛢️ Global Trigger
⚠️ Brent Crude: $77.96 (+2.6%)
🌍 Rising tensions around the Strait of Hormuz kept volatility elevated.

📈 Earnings Highlight
🚀 HCLTech Q1
✅ Profit up 20.3% YoY
🤖 Advanced AI revenue up 62.1% YoY
💡 Positive signal for the ongoing IT earnings season.

🎯 Technical View
🟢 Support: 24,200
🔴 Resistance: 24,400
📌 Holding above 24,200 keeps the short-term trend constructive.

👀 What to Watch Tomorrow
📊 FII vs DII flows
📢 More Q1 earnings announcements
🌍 US-Iran developments & crude oil prices
💻 Follow-through buying in the IT sector

💡 My View: Despite geopolitical uncertainty and FII selling, the market showed resilience. Strong earnings are beginning to outweigh macro fears—a positive sign if this trend continues.

#GiftNifty #Nifty50 #Sensex #StockMarket #IndianMarkets #Investing #MarketWrap #FII #DII #EarningsSeason #HCLTech #ITStocks #DalalStreet

[ParthOnGrowth @ParthOnGrowth]

📅 Market Outlook | Week Ahead (July 13–17)

📊 Last Week vs This Week
• Last week: High volatility driven by geopolitical fears.
• This week: Focus shifts to Q1 earnings and cautious recovery.
• Expected Nifty range: 24,000–24,400
• India VIX easing towards 12–12.5, indicating lower fear.

🔍 What Happened Last Week?
• Renewed US-Iran tensions triggered a sharp sell-off.
• Brent crude surged, hurting sentiment.
• Nifty witnessed a sharp mid-week correction before recovering.
• Banking, Auto & Paint sectors were the biggest laggards.
• Strong TCS Q1 results helped markets recover towards the weekend.

📅 Key Events This Week
• July 14: HCLTech Q1 Results
• July 15: Tata Elxsi, LTTS
• July 17: Wipro, Tech Mahindra, Polycab
• July 18: Reliance Industries, JSW Steel, RBL Bank, ICICI Lombard

📈 Technical View
• Immediate Support: 24,100–24,000
• Resistance: 24,400–24,500
• Holding above 24,100 keeps the bullish structure intact.
• A breakout above 24,400 could pave the way for fresh highs.

🌍 Global Triggers
• US-Iran developments remain the biggest risk.
• Crude oil prices will be closely watched.
• Any geopolitical escalation could increase market volatility.

⚡ What I’m Watching
• Q1 earnings quality and management commentary.
• FII/DII flows after recent volatility.
• Price action around the 24,200–24,400 zone.
• Stock-specific opportunities likely to outperform the index.

💬 My view: The market has shown resilience despite geopolitical shocks. If global tensions don’t escalate further, earnings could become the next major catalyst for the bulls.

Question: Will Nifty reclaim 24,500 this week or continue consolidating? 👇

[ParthOnGrowth @ParthOnGrowth]

Over the past few days, I’ve been researching high-quality Indian businesses.

These companies stood out for their high ROE, strong cash generation, asset-light business models, and long-term wealth creation potential.

🧬 Zydus Lifesciences
📊 ROE: ~25% | P/E: ~22x | P/B: ~4.6x

📈 CARE Ratings
📊 ROE: ~20% | P/E: ~34x | P/B: ~6.5x

⚡ Indian Energy Exchange (IEX)
📊 ROE: ~39% | P/E: ~22x | P/B: ~8.2x

🤖 eClerx Services
📊 ROE: ~36% | P/E: ~33x | P/B: ~12.6x

🚆 IRCTC
📊 ROE: ~35% | P/E: ~45x | P/B: ~16x

☀️ Waaree Energies
📊 ROE: ~35% | P/E: ~45x | P/B: ~10x

💻 Newgen Software
📊 ROE: ~24% | P/E: ~55x | P/B: ~11x

💊 Lupin
📊 ROE: ~20% | P/E: ~29x | P/B: ~5.5x

🌍 BLS International
📊 ROE: ~30% | P/E: ~28x | P/B: ~6x

🚗 KPIT Technologies
📊 ROE: ~35% | P/E: ~55x | P/B: ~18x

Common characteristics I found across these businesses:

✅ High ROE
💰 Strong cash generation
🏦 Low debt
🏆 Asset-light business models
📈 Structural growth tailwinds
👨‍💼 Proven management execution

These aren’t buy recommendations—just companies that have earned a place on my long-term watchlist after extensive fundamental research.

Not SEBI registered. Views are personal. Please do your own research before investing.

#IndianStocks #Investing #LongTermInvesting #StockMarket #WealthCreation #Nifty

[ParthOnGrowth @ParthOnGrowth]

7/7

📌 My investment thesis:

Zydus isn’t trying to become the next Novo Nordisk or Eli Lilly overnight.

Instead, it’s building a diversified healthcare business with multiple growth engines:

✅ India Branded Business
✅ US Generics
✅ GLP-1 Opportunity
✅ Vaccines
✅ Biosimilars
✅ Specialty Medicines
✅ Strong Financials

If management continues to execute well, I believe Zydus has the potential to remain one of India’s leading pharmaceutical compounders over the next decade.

Not SEBI registered. Views are personal. Please do your own research before investing.

#Zydus #IndianStocks #LongTermInvesting #StockMarket

[ParthOnGrowth @ParthOnGrowth]

1/7 🧵

What if I told you one Indian pharma company is quietly building businesses across:

💊 Generic Drugs
💉 GLP-1
🧬 Biosimilars
🦠 Vaccines
🏥 Specialty Medicines
🌍 50+ Countries

Yet it’s still not talked about enough.

Let’s understand why Zydus Lifesciences deserves a place on every long-term investor’s watchlist. 👇

#Zydus #IndianStocks

[ParthOnGrowth @ParthOnGrowth]

6/7

Every investment has risks.

For Zydus, I monitor:

⚠ USFDA inspections
⚠ US generic pricing pressure
⚠ Currency fluctuations
⚠ R&D execution
⚠ Competition from global pharma

These aren’t deal breakers—but they’re the key variables that can influence future earnings.

Good investing is about understanding both the opportunity and the risks.

#DYOR

[ParthOnGrowth @ParthOnGrowth]

#CDSL breakout confirmed. ✅

Back when I shared my analysis, the setup was clear:
• Strong business fundamentals
• Market leadership
• Healthy earnings growth
• Technical base formation

Today the chart has confirmed the thesis.

📈 Closed at ₹1,431.5
🔥 Breakout above the ₹1,400 resistance
📊 Strong volume (9.13M shares)
💪 Closed above the 20, 50 & 200 DMA
📈 RSI around 69 showing strong momentum

As long as ₹1,400 holds, the breakout remains valid.

The market rewards patience. First fundamentals, then price follows.

Not SEBI registered. This is not a buy/sell recommendation. Do your own research.

#CDSL #StockMarket #IndianStocks #Nifty #Investing #Breakout

[ParthOnGrowth @ParthOnGrowth]

📈 #CDSL CMP: ₹1,317
⚠️ Consolidating right at the 20 & 50 Daily EMAs (~₹1,317)
✅ Holding strong psychological support at ₹1,300
📊 RSI: 58.6 (Cooling off to neutral zone after the recent spike)

Following a sharp momentum rally mid-month fueled by structural market updates like the NSE IPO traction, the stock is currently undergoing a healthy pause to digest its gains.

🎯 Resistance: ₹1,375 → ₹1,400
🛡️ Support: ₹1,300 → ₹1,270

A strong base formation at these levels followed by a decisive daily close above ₹1,350 could re-trigger the bullish momentum and pave the way for ₹1,400+.

Disclosure: I hold a meaningful position in CDSL. Views are personal and shared purely for educational purposes. Not SEBI registered. Please do your own research.

#CDSL #Depository #Fintech #TechnicalAnalysis #IndianStockMarket #Nifty50 #Investing

[ParthOnGrowth @ParthOnGrowth]

✅ Business fundamentals remain exceptionally strong despite the recent concerns.
✅ FY26 delivered record Revenue (+84%), EBITDA (+117%) and PAT (+101%), showing execution remains intact.
✅ The CBP investigation is the biggest risk, but it is currently limited to a subset of historical imports and is under legal review.
✅ The ₹294.78 Cr provision reflects a conservative accounting approach rather than ignoring the issue.
✅ Auditors have issued a clean opinion; no material weakness in internal financial controls has been reported.
✅ The CEO and CFO transitions were planned, with experienced internal leaders taking over, reducing succession risk.
✅ The decline in operating cash flow appears largely linked to temporary inventory build-up and logistics disruptions rather than weak profitability.
✅ CARE’s upgrade to AA- (Stable) reflects confidence in the company’s improving scale, profitability, balance sheet, and capital structure.
✅ Waaree continues to maintain one of the strongest balance sheets and highest return ratios in the Indian renewable manufacturing sector.
✅ Management has consistently delivered on capacity expansion and earnings guidance, strengthening long-term credibility.
✅ The long-term growth drivers—solar manufacturing, cell integration, BESS, U.S. expansion, and India’s renewable push—remain firmly in place.
✅ For long-term investors, the focus should be on monitoring execution and regulatory developments rather than reacting to short-term market noise.
🎯 Current View: The long-term investment thesis remains intact, while the CBP investigation and cash flow normalization are the two key monitorables over the next few quarters.

[ParthOnGrowth @ParthOnGrowth]

Thread 🧵: Why I'm Bullish on Waaree Energies (#WaareeEnergies) for the Long Term

1/7 🚀

Waaree Energies has quietly transformed from a solar module manufacturer into a fully integrated clean energy company.

This isn't just a "solar stock" anymore.

It is building capabilities across:
✅ Solar Modules
✅ Solar Cells
✅ Ingot & Wafer
✅ BESS
✅ Inverters
✅ Green Hydrogen
✅ U.S. Manufacturing
Let's look at the numbers. 👇

[ParthOnGrowth @ParthOnGrowth]

📊 Stock Market Closing Wrap | July 9

Yesterday’s panic. Today’s recovery.

The headline indices bounced back, but the real positive was the market breadth.

✅ Nifty +0.34%
✅ Bank Nifty +0.90%
✅ 2,282 stocks advanced vs 707 declined
✅ DIIs continued to support the market despite FII selling

I’ve summarized everything that mattered today—from institutional flows and global cues to the key technical levels and what’s next for Nifty.

👇 Full market wrap in the infographic.

#Nifty50 #Sensex #GiftNifty #StockMarket #IndianMarkets #Investing #DalalStreet #MarketUpdate #FII #DII #Trading #Markets

[ParthOnGrowth @ParthOnGrowth]

7/7 🎯 My takeaway

Why I continue to track Waaree closely:

✅ Revenue compounding
✅ PAT growing faster than sales
✅ High ROCE/ROE
✅ Low leverage
✅ Large growth runway
✅ Integrated manufacturing strategy
✅ Strong execution so far

The next few years will determine whether Waaree becomes a global clean-energy manufacturing leader—not just India's largest solar module company.

Disclosure: Invested. This is not investment advice.
Please do your own research.

#WaareeEnergies #IndianStockMarket #StockMarketIndia #Investing #SolarEnergy #RenewableEnergy #Waaree #Nifty #Sensex

[ParthOnGrowth @ParthOnGrowth]

6/7 ⚠️ No company is risk-free.

The biggest risks I see are:

• Solar module price corrections
• Margin normalization as industry capacity expands
• Chinese competition
• Policy and tariff changes
• Execution risk from multiple large capex projects

A great business can still deliver poor returns if execution slips or valuation gets ahead of fundamentals.